Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab-Reference-Cited by-同舟云学术

Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab

Published:2020-10-12 Issue:12 Volume:11 Page:3521-3527
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Minemura Hiroyuki¹^ORCID,Moriya Hiroshi²,Imai Hisao³⁴^ORCID,Sugiyama Tomohide⁵,Yamada Yutaka⁶,Higuchi Mitsunori⁷,Kaira Kyoichi⁴^ORCID,Ozaki Yuki⁸,Kanazawa Kenya¹⁹,Yokouchi Hiroshi¹⁰,Kasai Takashi⁵,Kaburagi Takayuki⁶,Suzuki Hiroyuki⁸,Minato Koichi³,Shibata Yoko¹

Affiliation:

1. Department of Pulmonary Medicine Fukushima Medical University Fukushima Japan

2. Diagnostic Imaging Center Ohara General Hospital Fukushima Japan

3. Division of Respiratory Medicine Gunma Prefectural Cancer Center Ota Japan

4. Department of Respiratory Medicine, International Medical Center Saitama Medical University Hidaka Japan

5. Division of Thoracic Oncology Tochigi Cancer Center Utsunomiya Japan

6. Division of Respiratory Medicine Ibaraki Prefectural Central Hospital Kasama Japan

7. Department of Thoracic Surgery, Aizu Medical Center Fukushima Medical University Aizuwakamatsu Japan

8. Department of Chest Surgery Fukushima Medical University School of Medicine Fukushima Japan

9. Clinical Oncology Center Fukushima Medical University Hospital Fukushima Japan

10. Department of Respiratory Medicine National Hospital Organization Hokkaido Cancer Center Sapporo Japan

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13695

Reference25 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. PD-1 and Its Ligands in Tolerance and Immunity

3. Programmed death ligand-1 expression in non-small cell lung cancer

4. In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

5. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma;Cancer Management and Research;2021-07